176 related articles for article (PubMed ID: 8258830)
1. Further studies of the structure-activity relationships of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine. Synthesis and evaluation of 1-(2-benzo[b]thienyl)-N,N-dialkylcyclohexylamines at dopamine uptake and phencyclidine binding sites.
He X; Raymon LP; Mattson MV; Eldefrawi ME; de Costa BR
J Med Chem; 1993 Dec; 36(25):4075-81. PubMed ID: 8258830
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites.
He XS; Raymon LP; Mattson MV; Eldefrawi ME; de Costa BR
J Med Chem; 1993 Apr; 36(9):1188-93. PubMed ID: 8098066
[TBL] [Abstract][Full Text] [Related]
3. [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex.
Vignon J; Pinet V; Cerruti C; Kamenka JM; Chicheportiche R
Eur J Pharmacol; 1988 Apr; 148(3):427-36. PubMed ID: 3384005
[TBL] [Abstract][Full Text] [Related]
4. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
Akunne HC; Dersch CM; Cadet JL; Baumann MH; Char GU; Partilla JS; de Costa BR; Rice KC; Carroll FI; Rothman RB
J Pharmacol Exp Ther; 1994 Mar; 268(3):1462-75. PubMed ID: 7908058
[TBL] [Abstract][Full Text] [Related]
5. Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter.
Reith ME; de Costa B; Rice KC; Jacobson AE
Eur J Pharmacol; 1992 Dec; 227(4):417-25. PubMed ID: 1446712
[TBL] [Abstract][Full Text] [Related]
6. Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs.
Chaudieu I; Vignon J; Chicheportiche M; Kamenka JM; Trouiller G; Chicheportiche R
Pharmacol Biochem Behav; 1989 Mar; 32(3):699-705. PubMed ID: 2544905
[TBL] [Abstract][Full Text] [Related]
7. [3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex.
Akunne HC; Reid AA; Thurkauf A; Jacobson AE; de Costa BR; Rice KC; Heyes MP; Rothman RB
Synapse; 1991 Aug; 8(4):289-300. PubMed ID: 1833849
[TBL] [Abstract][Full Text] [Related]
8. Localization of the dopamine uptake complex using [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP) in rat brain.
Filloux F; Hunt MA; Wamsley JK
Neurosci Lett; 1989 May; 100(1-3):105-10. PubMed ID: 2527343
[TBL] [Abstract][Full Text] [Related]
9. Modulation by dopamine of [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP, a phencyclidine derivative) binding to the dopamine uptake complex.
Maurice T; Barbanel G; Kamenka JM; Vignon J
Neuropharmacology; 1991 Jun; 30(6):591-8. PubMed ID: 1681444
[TBL] [Abstract][Full Text] [Related]
10. The low affinity PCP sites in the rat cerebellum not only bind TCP-like but also BTCP-like structures.
Espaze F; Hamon J; Hirbec H; Vignon J; Kamenka JM
Eur J Med Chem; 2000 Mar; 35(3):323-31. PubMed ID: 10785558
[TBL] [Abstract][Full Text] [Related]
11. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter.
Rothman RB; Grieg N; Kim A; De Costa BR; Rice KC; Carroll FI; Pert A
Pharmacol Biochem Behav; 1992 Dec; 43(4):1135-42. PubMed ID: 1475296
[TBL] [Abstract][Full Text] [Related]
12. In vivo labelling of the mouse dopamine uptake complex with the phencyclidine derivative [3H]BTCP.
Maurice T; Vignon J; Kamenka JM; Chicheportiche R
Neurosci Lett; 1989 Jun; 101(2):234-8. PubMed ID: 2771169
[TBL] [Abstract][Full Text] [Related]
13. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
Koek W; Colpaert FC; Woods JH; Kamenka JM
J Pharmacol Exp Ther; 1989 Sep; 250(3):1019-27. PubMed ID: 2674416
[TBL] [Abstract][Full Text] [Related]
14. Localization of dopamine carriers by BTCP, a dopamine uptake inhibitor, on nigral cells cultured in vitro.
Cerruti C; Drian MJ; Kamenka JM; Privat A
Brain Res; 1991 Jul; 555(1):51-7. PubMed ID: 1681995
[TBL] [Abstract][Full Text] [Related]
15. 1-[1-2-Benzo[b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vitro: synthesis, identification from rat liver microsome extracts, and affinity for the neuronal dopamine transporter.
Deleuze-Masquefa C; Michaud M; Vignon J; Kamenka JM
J Med Chem; 1997 Dec; 40(25):4019-25. PubMed ID: 9406593
[TBL] [Abstract][Full Text] [Related]
16. 3-OH-pip-BTCP, a metabolite of the potent DA uptake blocker BTCP, exerts cocaine-like action in rats.
Martin-Fardon R; Lorentz CU; Kamenka JM; Weiss F
Neuroreport; 2003 Dec; 14(18):2439-44. PubMed ID: 14663207
[TBL] [Abstract][Full Text] [Related]
17. 1-[1-(2-Benzo[b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vivo. Identification and quantification of BTCP primary metabolites in mice plasma, urine, and brain and their affinity for the neuronal dopamine transporter.
Deleuze-Masquefa C; Michaud-Dutreilh M; Vignon J; Kamenka JM
Eur J Pharm Sci; 2000 Feb; 9(4):345-54. PubMed ID: 10664474
[TBL] [Abstract][Full Text] [Related]
18. Endogenous dopamine differently affects N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine and cocaine binding to the dopamine uptake complex.
Maurice T; Barbanel G; Vignon J
Gen Pharmacol; 1993 Jan; 24(1):191-4. PubMed ID: 8482495
[TBL] [Abstract][Full Text] [Related]
19. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
Rothman RB; Reid AA; Monn JA; Jacobson AE; Rice KC
Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
[TBL] [Abstract][Full Text] [Related]
20. N-[1-(2-Benzo(b)thiophenyl)cyclohexyl]piperidine (BTCP) and cocaine induce similar effects on striatal dopamine: a microdialysis study in freely moving rats.
Martin-Fardon R; Arnaud M; Rousseau E; Kamenka JM; Privat A; Vignon J
Neurosci Lett; 1996 Jun; 211(3):179-82. PubMed ID: 8817570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
